Comprehensive, easy-to-understand information about this condition
How we create this content →The documentation for amyotrophic lateral sclerosis type 23 is limited primarily due to its rarity, which restricts the number of systematic clinical studies. Furthermore, the genetic basis was only recently identified, and ongoing research is needed to fully characterize the clinical features and natural history of this condition.
The primary clinical feature of ALS23 is amyotrophic lateral sclerosis, which leads to progressive muscle weakness and atrophy. Additionally, dysphagia, or difficulty swallowing, affects a significant portion of individuals, complicating nutritional intake and overall health. These symptoms may vary in severity and onset among affected individuals.
To navigate amyotrophic lateral sclerosis type 23, consider consulting a neurologist with expertise in motor neuron diseases or hereditary ataxias. While there are currently no designated patient organizations, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information. Genetic counseling may also be beneficial for understanding the implications of the ANXA11 gene variant for you and your family. Additionally, inquire about any available patient registries or natural history studies that may be in development.
Actionable guidance for navigating care for amyotrophic lateral sclerosis type 23
To navigate amyotrophic lateral sclerosis type 23, consider consulting a neurologist with expertise in motor neuron diseases or hereditary ataxias. While there are currently no designated patient organizations, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information. Genetic counseling may also be beneficial for understanding the implications of the ANXA11 gene variant for you and your family. Additionally, inquire about any available patient registries or natural history studies that may be in development.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation for amyotrophic lateral sclerosis type 23 is limited primarily due to its rarity, which restricts the number of systematic clinical studies. Furthermore, the genetic basis was only recently identified, and ongoing research is needed to fully characterize the clinical features and natural history of this condition.
The primary clinical feature of ALS23 is amyotrophic lateral sclerosis, which leads to progressive muscle weakness and atrophy. Additionally, dysphagia, or difficulty swallowing, affects a significant portion of individuals, complicating nutritional intake and overall health. These symptoms may vary in severity and onset among affected individuals.
To navigate amyotrophic lateral sclerosis type 23, consider consulting a neurologist with expertise in motor neuron diseases or hereditary ataxias. While there are currently no designated patient organizations, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information. Genetic counseling may also be beneficial for understanding the implications of the ANXA11 gene variant for you and your family. Additionally, inquire about any available patient registries or natural history studies that may be in development.
Actionable guidance for navigating care for amyotrophic lateral sclerosis type 23
To navigate amyotrophic lateral sclerosis type 23, consider consulting a neurologist with expertise in motor neuron diseases or hereditary ataxias. While there are currently no designated patient organizations, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information. Genetic counseling may also be beneficial for understanding the implications of the ANXA11 gene variant for you and your family. Additionally, inquire about any available patient registries or natural history studies that may be in development.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation for amyotrophic lateral sclerosis type 23 is limited primarily due to its rarity, which restricts the number of systematic clinical studies. Furthermore, the genetic basis was only recently identified, and ongoing research is needed to fully characterize the clinical features and natural history of this condition.
The primary clinical feature of ALS23 is amyotrophic lateral sclerosis, which leads to progressive muscle weakness and atrophy. Additionally, dysphagia, or difficulty swallowing, affects a significant portion of individuals, complicating nutritional intake and overall health. These symptoms may vary in severity and onset among affected individuals.
To navigate amyotrophic lateral sclerosis type 23, consider consulting a neurologist with expertise in motor neuron diseases or hereditary ataxias. While there are currently no designated patient organizations, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information. Genetic counseling may also be beneficial for understanding the implications of the ANXA11 gene variant for you and your family. Additionally, inquire about any available patient registries or natural history studies that may be in development.
Actionable guidance for navigating care for amyotrophic lateral sclerosis type 23
To navigate amyotrophic lateral sclerosis type 23, consider consulting a neurologist with expertise in motor neuron diseases or hereditary ataxias. While there are currently no designated patient organizations, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information. Genetic counseling may also be beneficial for understanding the implications of the ANXA11 gene variant for you and your family. Additionally, inquire about any available patient registries or natural history studies that may be in development.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.